D-Index & Metrics Best Publications
Biology and Biochemistry
Australia
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 63 Citations 12,592 318 World Ranking 5411 National Ranking 134
Biology and Biochemistry D-index 80 Citations 21,943 425 World Ranking 2577 National Ranking 57

Research.com Recognitions

Awards & Achievements

2023 - Research.com Biology and Biochemistry in Australia Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Cancer
  • Gene

Ian J. Stratford mainly focuses on Cancer research, Radiation therapy, Biochemistry, In vivo and In vitro. Ian J. Stratford has included themes like Hypoxia, Gene expression, Chemotherapy, Immunology and Cancer therapy in his Cancer research study. The concepts of his Hypoxia study are interwoven with issues in Molecular biology, Transcription factor and Pathology.

His Radiation therapy research integrates issues from Cancer and Immune system. His Biochemistry research is multidisciplinary, incorporating perspectives in Cell culture and Toxicity. His studies in In vivo integrate themes in fields like Endocrinology, Radiosensitivity, Internal medicine, Angiogenesis and Glycolysis.

His most cited work include:

  • Guidelines for the welfare and use of animals in cancer research (937 citations)
  • Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. (921 citations)
  • Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade (577 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Cancer research, Pharmacology, Biochemistry, In vitro and Hypoxia. His Cancer research study combines topics from a wide range of disciplines, such as Cancer, Immunology, Pathology, Genetic enhancement and Radiation therapy. His study looks at the relationship between Pharmacology and fields such as Misonidazole, as well as how they intersect with chemical problems.

He interconnects Toxicity and In vivo in the investigation of issues within In vitro. The various areas that Ian J. Stratford examines in his Hypoxia study include Carcinoma and Chemotherapy. Ian J. Stratford usually deals with Cytotoxicity and limits it to topics linked to Cell culture and Molecular biology.

He most often published in these fields:

  • Cancer research (27.92%)
  • Pharmacology (18.40%)
  • Biochemistry (17.75%)

What were the highlights of his more recent work (between 2009-2020)?

  • Cancer research (27.92%)
  • Cancer (9.09%)
  • Radiation therapy (10.82%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Cancer research, Cancer, Radiation therapy, Internal medicine and Stereochemistry. His research in Cancer research intersects with topics in Cell culture, Radiosensitivity, Cancer cell, Monocarboxylate transporter and In vivo. As part of the same scientific family, Ian J. Stratford usually focuses on Cancer, concentrating on Hyaluronic acid and intersecting with Gene isoform and Cell.

His studies in Radiation therapy integrate themes in fields like Agonist, Immunology, Immune system and Pathology. The various areas that he examines in his Internal medicine study include Endocrinology and Oncology. His Stereochemistry research incorporates themes from Combinatorial chemistry, Anti tumour, Quinone oxidoreductase and Enzyme.

Between 2009 and 2020, his most popular works were:

  • Guidelines for the welfare and use of animals in cancer research (937 citations)
  • Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade (577 citations)
  • Site and strain-specific variation in gut microbiota profiles and metabolism in experimental mice. (159 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Cancer
  • Gene

Cancer research, Biochemistry, Radiation therapy, Cancer and Hyaluronic acid are his primary areas of study. His biological study spans a wide range of topics, including Radiosensitivity, Cancer cell, Glycolysis, Monocarboxylate transporter 1 and In vivo. His work carried out in the field of Radiosensitivity brings together such families of science as Cell culture, Tumor hypoxia, Tumor Oxygenation and Pathology.

His Radiation therapy study incorporates themes from Immune system and Immunology. His research integrates issues of Clinical trial and Transplantation in his study of Cancer. His study on Hyaluronic acid also encompasses disciplines like

  • Receptor which is related to area like Gene isoform and Cell,
  • Internalization that intertwine with fields like Cancer therapy and Cell biology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

P H Maxwell;G U Dachs;J M Gleadle;L G Nicholls.
Proceedings of the National Academy of Sciences of the United States of America (1997)

1333 Citations

Guidelines for the welfare and use of animals in cancer research

P Workman;E O Aboagye;F Balkwill;A Balmain.
British Journal of Cancer (2010)

1310 Citations

Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade

Simon J. Dovedi;Amy L. Adlard;Grazyna Lipowska-Bhalla;Conor McKenna.
Cancer Research (2014)

897 Citations

Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix.

Juliette A. Loncaster;Adrian L. Harris;Susan E. Davidson;John P. Logue.
Cancer Research (2001)

702 Citations

Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361

Christopher R. Calabrese;Robert Almassy;Stephanie Barton;Michael A. Batey.
Journal of the National Cancer Institute (2004)

545 Citations

Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers.

G. E. Adams;I. R. Flockhart;C. E. Smithen;I. J. Stratford.
Radiation Research (1976)

486 Citations

Targeting gene expression to hypoxic tumor cells.

G.U Dachs;Aa.V Patterson;Aa.V Patterson;J.D Firth;P.J Ratcliffe.
Nature Medicine (1997)

453 Citations

Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance.

Janine T Erler;Christopher Cawthorne;Kaye J Williams;Marianne Koritzinsky.
Molecular and Cellular Biology (2004)

439 Citations

Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.

R Airley;Juliette A Loncaster;Susan E Davidson;Michael Bromley.
Clinical Cancer Research (2001)

417 Citations

Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency

G.E. Adams;E.D. Clarke;I.R. Flockhart;R.S. Jacobs.
International Journal of Radiation Biology (1979)

310 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Ian J. Stratford

adrian l harris

adrian l harris

University of Oxford

Publications: 131

Claudiu T. Supuran

Claudiu T. Supuran

University of Florence

Publications: 79

William R. Wilson

William R. Wilson

University of Auckland

Publications: 62

Paul Workman

Paul Workman

Institute of Cancer Research

Publications: 54

Catharine M L West

Catharine M L West

University of Manchester

Publications: 51

Suzanne A. Eccles

Suzanne A. Eccles

Institute of Cancer Research

Publications: 50

Kevin J. Harrington

Kevin J. Harrington

Royal Marsden NHS Foundation Trust

Publications: 49

J. Martin Brown

J. Martin Brown

Stanford University

Publications: 47

Mark W. Dewhirst

Mark W. Dewhirst

Duke University

Publications: 43

William A. Denny

William A. Denny

University of Auckland

Publications: 42

John R. Griffiths

John R. Griffiths

University of Manchester

Publications: 41

Jens Overgaard

Jens Overgaard

Aarhus University Hospital

Publications: 37

Richard P. Hill

Richard P. Hill

Princess Margaret Cancer Centre

Publications: 35

Gregg L. Semenza

Gregg L. Semenza

Johns Hopkins University School of Medicine

Publications: 32

Peter Wardman

Peter Wardman

Mount Vernon Hospital

Publications: 30

Patrick H. Maxwell

Patrick H. Maxwell

University of Cambridge

Publications: 30

Trending Scientists

Kiyokatsu Jinno

Kiyokatsu Jinno

Toyohashi University of Technology

Burtron H. Davis

Burtron H. Davis

University of Kentucky

Arnaud Estoup

Arnaud Estoup

University of Montpellier

Frithjof C. Küpper

Frithjof C. Küpper

University of Aberdeen

Alejandro H. Buschmann

Alejandro H. Buschmann

University of Los Lagos

Jonathan M. Scholey

Jonathan M. Scholey

University of California, Davis

Vincenzo Lapenna

Vincenzo Lapenna

National Academies of Sciences, Engineering, and Medicine

W. R. Leaitch

W. R. Leaitch

Environment and Climate Change Canada

Angela Wulff

Angela Wulff

University of Gothenburg

Milena Botelho Pereira Soares

Milena Botelho Pereira Soares

Oswaldo Cruz Foundation

Grace M. Lee

Grace M. Lee

Stanford University

Menno V. Huisman

Menno V. Huisman

Leiden University Medical Center

Steven P. Roose

Steven P. Roose

Columbia University

C. Michael Stein

C. Michael Stein

Vanderbilt University Medical Center

Kenner C. Rice

Kenner C. Rice

National Institutes of Health

Phyllis C. Blumenfeld

Phyllis C. Blumenfeld

University of Michigan–Ann Arbor

Something went wrong. Please try again later.